Savara Inc. (SVRA)
Nasdaq: SVRA · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2001
Who owns Savara Inc.
As filed with the SECHolders of 5% or more
7
Growth Equity Opportunities 17, LLC holds 12% of Common Stock, par value $0.001 per share, as its SCHEDULE 13D/A filed Nov 14, 2025 says.
Directors and officers
12
report now, of 26 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Growth Equity Opportunities 17, LLC
SCHEDULE 13D/A · filed Nov 14, 2025 · Common Stock, par value $0.001 per share
Bain Capital Life Sciences Fund II, L.P.
SCHEDULE 13D/A · filed Mar 27, 2025 · Common Stock, par value $0.001 per share
Venrock Healthcare Capital Partners III, L.P.
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.001 per share · 7.3% in Nov 14, 2025
Dapice Joshua J.
SCHEDULE 13G/A · filed Feb 5, 2026 · Common Stock, par value $0.001 per share (the "Shares") · 9.99% in Feb 11, 2025
Deerfield Mgmt, L.P.
SCHEDULE 13G · filed Nov 5, 2025 · Common Stock
TCG Crossover GP I, LLC
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, $0.001 par value per share
Blackrock, Inc.
SCHEDULE 13G · filed Jan 21, 2026 · Common Stock · 4.8% in Oct 17, 2025
Frazier Life Sciences Public Fund, L.P.
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 3.9% in Aug 14, 2025
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.08% in Nov 14, 2025
Wellington Management Group LLP
SCHEDULE 13G/A · filed Feb 10, 2025 · Common Stock · reported falling below 5%
Vestal Point Capital, LP
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.3% in Feb 14, 2025
What SVRA reports owning in othersstakes of 5% or more, and other ties
Savara Inc. reports no stake in another company in the record.
Insider tradesForm 4
2sales
0purchases
0sales on a scheduled plan
2people selling
$2.4Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 45 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Lowrance David L | Chief Financial Officer | 1 | $2.2M | 0 | 0 | $0 |
| Ramsay David A | director | 1 | $100,000 | 0 | 0 | $0 |